Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ANIP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ANIP

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

ANI Pharmaceuticals Inc

ANIP
Current price
68.04 USD +1.67 USD (+2.52%)
Last closed 64.00 USD
ISIN US00182C1036
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 431 137 664 USD
Yield for 12 month +10.90 %
1Y
3Y
5Y
10Y
15Y
ANIP
21.11.2021 - 28.11.2021

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota. Address: 210 Main Street West, Baudette, MN, United States, 56623

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

81.17 USD

P/E Ratio

Dividend Yield

Financials ANIP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ANIP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+614 376 000 USD

Last Year

+486 816 000 USD

Current Quarter

+197 122 000 USD

Last Quarter

+190 574 000 USD

Current Year

+364 166 000 USD

Last Year

+305 303 000 USD

Current Quarter

+124 085 000 USD

Last Quarter

+110 294 000 USD
EBITDA 90 501 000 USD
Operating Margin TTM 7.61 %
Price to Earnings
Return On Assets TTM 0.83 %
PEG Ratio 1.06
Return On Equity TTM -4.57 %
Wall Street Target Price 81.17 USD
Revenue TTM 674 067 968 USD
Book Value 20.90 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 43.40 %
Dividend Yield
Gross Profit TTM 399 977 984 USD
Earnings per share -1.18 USD
Diluted Eps TTM -1.18 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -16.90 %
Profit Margin -3.12 %

Stock Valuation ANIP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 9.90
Enterprise Value Revenue 2.83
Price Sales TTM 2.12
Enterprise Value EBITDA 28.51
Price Book MRQ 3.38

Technical Indicators ANIP

For 52 Weeks

52.50 USD 77.00 USD
50 Day MA 64.04 USD
Shares Short Prior Month 2 013 161
200 Day MA 60.78 USD
Short Ratio 6.01
Shares Short 2 005 000
Short Percent 11.69 %